DNA probes and PCR for diagnosis of parasitic infections.
DNA probe and PCR-based assays to identify and detect parasites are technically complex; however, they have high sensitivity, directly detect parasites independent of the immunocompetence or previous clinical history of the patient, and can distinguish between organisms that are morphologically similar. Diagnosis of parasites is often based on direct detection by microscopy, which is insensitive and laborious and can lack specificity. Most PCR-based assays were more sensitive than DNA probe assays. The development of PCR-based diagnostic assays requires multiple steps following the initial selection of oligonucleotide primers and reporter probe. Generally, the ability to detect the DNA of one parasite was attained by PCR; however, advances in the preparation of samples for PCR (extraction of DNA while removing PCR inhibitors) will be required to achieve that sensitivity with human specimens. Preliminary PCR systems have been developed for many different parasites, yet few have been evaluated with a large number of clinical specimens and/or under field conditions. Those evaluations are essential for determination of clinical and field utility and performance and of the most appropriate application of the assay. Several situations in which PCR-based diagnosis will result in epidemiologic, medical, or public health advances have been identified.
Weiss
J B
JB
Department of Infectious Diseases, Roche Molecular Systems, Alameda, California 94501.
D000818:Animals; D015342:DNA Probes; D006801:Humans; D007896:Leishmaniasis / Q000175:diagnosis; D008288:Malaria / Q000175:diagnosis; D009349:Nematode Infections / Q000175:diagnosis*; D016133:Polymerase Chain Reaction; D011528:Protozoan Infections / Q000175:diagnosis*; D014352:Trypanosomiasis / Q000175:diagnosis
D015342:DNA Probes